The abstract is read at the publisher; the summary is JClub's.
Within-patient resistant glioblastoma stem-like cell families show that TMZ selection yields mismatch repair-dependent stable resistance or drug tolerance, while IR selection increases radioresistance.
- Why it matters: Resistance evolution in GBM is hard to mechanistically study because matched primary-to-recurrent experimental models are scarce and chemotherapy versus radiotherapy effects are often confounded.
- What they did: The authors built an ex vivo platform deriving temozolomide- and ionizing radiation–selected GSCs from the same primary GBM, alongside treatment-naive controls, then compared MGMT-negative selection outcomes.
- The result: Emergent GSCs accumulate chromosomal alterations and share genome maintenance transcriptional programs; IR-selected cells show stronger DNA double-strand-break repair pathway enrichment and increased receptor tyrosine kinase activity, enabling hypothesis-driven strategy testing.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.